← SynDRA
darolutamide
SynDRA canonical compound SYN0041289 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · Rx |
| Primary target(s) | AR |
| Mechanism of action | androgen receptor antagonist |
| Indication | breast cancer | prostate cancer |
| Disease area | oncology |
All known targets
Mechanisms of action (all sources)
- AR ANTAGONIST
- AR INHIBITOR
ATC classes
- HORMONE ANTAGONISTS AND RELATED AGENTS
Cross-references
Synonyms
- nubeqa
- BAY 1841788
- ODM-201
- SCHEMBL17962572
- SCHEMBL26312360
- SCHEMBL29519795
- NS00073387
- Z8157594654
Look up darolutamide in the interactive SynDRA portal →